Memorial Göztepe Hospital
Memorial Göztepe Hospital
Turkey, Istanbul
Stem cell transplant for scleroderma in Istanbul typically costs from $45,000 to $65,000. The total fee depends on the specific protocol used and the length of isolation required. Patients save around 68% compared to the US, where this procedure costs $220,000 on average. These packages usually include high-dose chemotherapy, stem cell harvesting, and extended hospitalization.
Bookimed Expert Insight: Istanbul serves as Turkey's primary hub for complex hematology, offering deeper specialty depth than regional cities. Major centers like Memorial Göztepe Hospital provide 55 intensive care units and 19 operating rooms. This infrastructure is vital for patients requiring the strict isolation protocols of autologous transplants. Experts like Dr. Emine Demir bring nearly three decades of experience in regenerative therapies to these protocols.
| Turkey | Austria | Spain | |
| Stem cell transplant for scleroderma | from $55,000 | from $80,000 | from $100,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Stem cell transplant for scleroderma upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Stem cell transplant for scleroderma and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Stem cell transplant for scleroderma journey.
Dr. Emine Demir is a licensed physician in Turkey. She holds an MD, diploma no. 97600435, issued by the Republic of Turkey Ministry of Health on 7 July 1997.
She has more than 28 years of experience in public and private care. Her practice focuses on dermatology and trichology. She treats hair and scalp disorders and provides alopecia diagnosis and post-transplant care. This includes female and male pattern hair loss.
At Istanbul Care Clinic, she offers diagnostic evaluations and scalp health consultations. She provides structured follow-up to support graft retention and scalp recovery. Her approach uses evidence-based protocols.
Istanbul hospitals perform hematopoietic stem cell transplants (HSCT) for scleroderma. Memorial Göztepe, Liv Hospital, and Acibadem are JCI-accredited centers that offer this procedure. They use specialized Bone Marrow Transplantation units and HEPA-filtered isolation rooms. These help reset the immune system for patients with severe systemic sclerosis.
Bookimed Expert Insight: While stem cell therapy is common, scleroderma requires a full immune reset. Memorial Göztepe stands out because it houses over 90 doctors and 19 operating rooms. This scale means multidisciplinary tumor boards review complex autoimmune cases before transplantation begins.
Patient Consensus: Patients emphasize verifying if a center performs hematopoietic transplants specifically rather than general injections. Successful outcomes depend on the seamless collaboration between your rheumatologist and the transplant specialist.
Autologous hematopoietic stem cell transplant (HSCT) uses chemotherapy to reset the immune system. In contrast, mesenchymal stem cell (MSC) therapy focuses on tissue repair without immunosuppression. HSCT is a standard, evidence-based intensive procedure. Meanwhile, MSC therapy remains an investigational, low-intensity outpatient alternative.
Bookimed Expert Insight: Istanbul hospitals like Memorial Göztepe use multidisciplinary tumor boards for intensive care. In contrast, smaller clinics focus on MSCs. Patients should look for facilities that perform full mobilization and conditioning chemotherapy. These treatments provide the disease-stopping benefits validated by international scleroderma research.
Patient Consensus: Patients often view HSCT as a hard reboot to stop progression. However, they warn that MSC therapy often involves more hype than proven results. Real-world experience suggests HSCT is more physically demanding. However, its ability to treat lung and skin involvement is more established.
Eligible candidates for stem cell transplants in Istanbul typically have active, rapidly progressing diffuse cutaneous systemic sclerosis. This is an autologous hematopoietic stem cell transplantation (AHSCT) for patients whose disease affects internal organs. It is especially meant for those who have not responded to standard immunosuppressive drugs like mycophenolate mofetil.
Bookimed Expert Insight: Only about 3% of scleroderma patients meet the strict criteria for this procedure. Major Istanbul networks like Memorial Health Group have over 25 years of experience. They use multidisciplinary tumor boards to screen candidates. This ensures patients are biologically fit enough to survive the intensive immune-system reset.
Patient Consensus: Patients emphasize that early screening is vital, especially for those with aggressive lung involvement. Patients also highlight that younger age with strong heart function greatly improves the chances of being accepted for treatment.
Stem cell transplant for scleroderma involves high-dose chemotherapy. This treatment carries risks like severe infections, organ toxicity, and treatment-related mortality. Patients may have acute gastrointestinal distress and profound cytopenias. The immune system reset process can lead to long-term risks like secondary autoimmune conditions or infertility.
Bookimed Expert Insight: Istanbul clinics like Memorial Göztepe Hospital use diagnostic tools to monitor organ function. These tools include 3 Tesla MRI and digital PET/CT. Patients should look for clinics with both cardiovascular and oncology departments. These departments allow prompt care if chemotherapy stresses the heart or lungs during engraftment.
Patient Consensus: Patients describe the procedure as a life-or-death decision with an intense recovery period. Patients emphasize that while it offers significant symptom relief, it is not a guaranteed cure.
Stem cell transplant for scleroderma is an intensive immunotherapy known as autologous hematopoietic stem cell transplantation. It involves using a patient's own blood-forming cells to reset a malfunctioning immune system. This procedure aims to halt progressive organ fibrosis and connective tissue damage.
Bookimed Expert Insight: Patients often associate stem cells with regenerative therapy. But in scleroderma transplants, the real therapeutic work happens during the intensive immunoablation phase. High-dose chemotherapy wipes out faulty immune cells before the infusion. Data shows that clinics like Memorial Göztepe Hospital use multidisciplinary tumor boards. These boards manage complex protocols and make sure the high-risk conditioning phase is tailored to each patient's lung and heart capacity.
Patient Consensus: Patients emphasize that this is a high-stakes, last-resort option rather than a gentle therapy. Success often means achieving drug-free remission and stopping further disease progression. It is not about reversing existing scarring.